National Institute of Allergy And Infectious Diseases; Notice of Closed Meetings, 96024 [2016-31610]

Download as PDF 96024 Federal Register / Vol. 81, No. 250 / Thursday, December 29, 2016 / Notices Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Building 31, Conference Room 10, 31 Center Drive, Bethesda, MD 20892. Open: 9:30 a.m. to 3:15 p.m. Agenda: A report from the Institute Director and other staff. Place: National Institutes of Health, Building 31, Conference Room 10, 31 Center Drive, Bethesda, MD 20892. Contact Person: Martin H. Goldrosen, Ph.D., Director, Division of Extramural Activities, National Center for Complementary and Integrative Health, NIH, 6707 Democracy Blvd., Ste. 401, Bethesda, MD 20892–5475, (301) 594–2014, goldrosm@mail.nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. In the interest of security, NIH has instituted stringent procedures for entrance onto the NIH campus. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver’s license, or passport) and to state the purpose of their visit. Information is also available on the Institute’s/Center’s home page: https:// nccih.nih.gov/about/naccih/, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.213, Research and Training in Complementary and Integrative Health, National Institutes of Health, HHS) Dated: December 22, 2016. Michelle Trout, Program Analyst, Office of Federal Advisory Committee Policy. and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; NIAID Peer Review Meeting. Date: January 11–12, 2017. Time: 7:00 a.m. to 12:00 p.m. Agenda: To review and evaluate contract proposals. Place: Hilton Garden Inn Savannah Historic District, Telfair Conference Room, 321 West Bay Street, Savannah, GA 31401. Contact Person: Ellen S. Buczko, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, Room #3F30A, National Institutes of Health/ NIAID, 5601 Fishers Lane, MSC 9823, Bethesda, MD 20892 –9823, (240) 669–5028, ebuczko1@niaid.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; NIAID Investigator Initiated Program Project Applications (P01). Date: January 25–26, 2017. Time: 10:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Room 3G53, 5601 Fishers Lane, Rockville, MD 20892 (Telephone Conference Call). Contact Person: Julio Aliberti, Scientific Review Officer, Scientific Review Program, DEA/NIAID/NIH/DHHS, 5601 Fishers Lane, MSC–9823, Rockville, MD 20852, 301–761– 7322, alibertijc@niaid.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: December 23, 2016. Natasha M. Copeland, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2016–31430 Filed 12–28–16; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES [FR Doc. 2016–31610 Filed 12–28–16; 8:45 am] BILLING CODE 4140–01–P National Institutes of Health asabaliauskas on DSK3SPTVN1PROD with NOTICES National Institute of Allergy And Infectious Diseases; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, VerDate Sep<11>2014 18:41 Dec 28, 2016 Jkt 241001 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Using Informatics To Improve Data Analysis of Chemical Screening Assays Conducted in Zebrafish; Notice of Webinars; Registration Information The National Toxicology Program (NTP) at the National Institute of Environmental Health Sciences announces the webinar series, ‘‘Using Informatics to Improve Data Analysis of Chemical Screening Assays Conducted in Zebrafish.’’ The webinars will SUMMARY: PO 00000 Frm 00069 Fmt 4703 Sfmt 4703 provide an overview of current issues that need to be addressed to facilitate the broader use of zebrafish for chemical safety screening studies and how data science can be applied to address some of those issues. DATES: First Webinar: February 2, 2017, from 11:30 a.m. to 1:00 p.m. Eastern Standard Time (EST). Subsequent Webinars: February 16, 2017; March 2, 2017; both webinars will be presented from 11:30 a.m. to 12:30 p.m. EST. Registration for Webinars: Registration will be open continuously; registration for any webinar will automatically register the participant for all subsequent webinars. ADDRESSES: Web page: The preliminary agenda, registration, and other meeting materials are at http://ntp.niehs.nih.gov/ go/zfweb-2017. FOR FURTHER INFORMATION CONTACT: Dr. Elizabeth Maull, NTP Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM), at telephone: (919) 316–4668 or email: maull@niehs.nih.gov. SUPPLEMENTARY INFORMATION: Background: The small size and rapid development of the zebrafish make it a useful vertebrate model for assessing potential effects of chemicals on development in a medium to highthroughput manner. However, a lack of harmonization in several key protocol components hinders the broader adoption of the zebrafish model for toxicological screening. In an effort to address this issue, NTP launched the Systematic Evaluation of the Application of Zebrafish in Toxicology (SEAZIT) program. SEAZIT is addressing the issues of variability among laboratories in the endpoints measured, as well as the nomenclature used for each endpoint. NICEATM is organizing a webinar series in support of the SEAZIT program that will consider how these issues might be addressed by implementation of standardized nomenclature systems, also known as ontologies. Webinars in this series will (1) summarize some of the barriers to routine use of zebrafish in toxicological evaluations, (2) review the concept of ontologies, and (3) consider how ontologies could be applied to harmonize procedures used for zebrafish screening studies. Webinar Topics and Other Information: A link to registration and additional information about the webinar series, including topics and speakers for all webinars, are available at http://ntp.niehs.nih.gov/go/zfweb2017. The webinar steering committee is E:\FR\FM\29DEN1.SGM 29DEN1

Agencies

[Federal Register Volume 81, Number 250 (Thursday, December 29, 2016)]
[Notices]
[Page 96024]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-31610]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy And Infectious Diseases; Notice of 
Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; NIAID Peer Review Meeting.
    Date: January 11-12, 2017.
    Time: 7:00 a.m. to 12:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: Hilton Garden Inn Savannah Historic District, Telfair 
Conference Room, 321 West Bay Street, Savannah, GA 31401.
    Contact Person: Ellen S. Buczko, Ph.D., Scientific Review 
Officer, Scientific Review Program, Division of Extramural 
Activities, Room #3F30A, National Institutes of Health/NIAID, 5601 
Fishers Lane, MSC 9823, Bethesda, MD 20892 -9823, (240) 669-5028, 
ebuczko1@niaid.nih.gov.

    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; NIAID Investigator Initiated 
Program Project Applications (P01).
    Date: January 25-26, 2017.
    Time: 10:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Room 3G53, 5601 Fishers 
Lane, Rockville, MD 20892 (Telephone Conference Call).
    Contact Person: Julio Aliberti, Scientific Review Officer, 
Scientific Review Program, DEA/NIAID/NIH/DHHS, 5601 Fishers Lane, 
MSC-9823, Rockville, MD 20852, 301-761-7322, 
alibertijc@niaid.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: December 23, 2016.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-31610 Filed 12-28-16; 8:45 am]
 BILLING CODE 4140-01-P